AU538599B2 - Compositions and treatment for hypertension - Google Patents

Compositions and treatment for hypertension

Info

Publication number
AU538599B2
AU538599B2 AU55742/80A AU5574280A AU538599B2 AU 538599 B2 AU538599 B2 AU 538599B2 AU 55742/80 A AU55742/80 A AU 55742/80A AU 5574280 A AU5574280 A AU 5574280A AU 538599 B2 AU538599 B2 AU 538599B2
Authority
AU
Australia
Prior art keywords
hypertension
compositions
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU55742/80A
Other languages
English (en)
Other versions
AU5574280A (en
Inventor
Walter H. Aellig
David Grenville Holmes
Pavel Jerie
Walter Schutz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU5574280A publication Critical patent/AU5574280A/en
Application granted granted Critical
Publication of AU538599B2 publication Critical patent/AU538599B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU55742/80A 1979-02-22 1980-02-20 Compositions and treatment for hypertension Ceased AU538599B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH178579A CH643457A5 (de) 1979-02-22 1979-02-22 Pharmazeutische praeparate zur behandlung der hypertonie.
CH178579 1979-02-22

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU82000/82A Division AU8200082A (en) 1979-02-22 1982-03-26 Sustained-release endralazine pharmaceutical composition

Publications (2)

Publication Number Publication Date
AU5574280A AU5574280A (en) 1980-08-28
AU538599B2 true AU538599B2 (en) 1984-08-23

Family

ID=4218544

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55742/80A Ceased AU538599B2 (en) 1979-02-22 1980-02-20 Compositions and treatment for hypertension

Country Status (20)

Country Link
JP (1) JPS55115823A (nl)
AT (1) AT378915B (nl)
AU (1) AU538599B2 (nl)
BE (1) BE881763A (nl)
CA (1) CA1147657A (nl)
CH (1) CH643457A5 (nl)
DE (1) DE3005029A1 (nl)
FR (1) FR2449450A1 (nl)
GB (1) GB2044101B (nl)
HU (1) HU187271B (nl)
IE (1) IE49073B1 (nl)
IL (1) IL59432A (nl)
IT (1) IT1145433B (nl)
MY (1) MY8500619A (nl)
NL (1) NL8001000A (nl)
NZ (1) NZ192924A (nl)
PH (1) PH17118A (nl)
PT (1) PT70855A (nl)
SE (2) SE8001121L (nl)
ZA (1) ZA801018B (nl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2537434A1 (fr) * 1982-12-09 1984-06-15 Sandoz Sa Composition pharmaceutique d'endralazine sous forme retard
GB2367242B (en) * 2000-09-21 2004-07-28 Henderson Morley Res & Dev Ltd Antiviral treatment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2458155A1 (de) * 1973-12-19 1975-07-03 Sandoz Ag Neue pharmazeutische praeparate

Also Published As

Publication number Publication date
HU187271B (en) 1985-12-28
CA1147657A (en) 1983-06-07
NZ192924A (en) 1984-05-31
IE800336L (en) 1980-08-22
ZA801018B (en) 1981-09-30
AU5574280A (en) 1980-08-28
DE3005029A1 (de) 1980-09-04
SE8001121L (sv) 1980-08-23
FR2449450A1 (fr) 1980-09-19
IL59432A0 (en) 1980-05-30
GB2044101B (en) 1983-09-07
PT70855A (fr) 1980-03-01
IT1145433B (it) 1986-11-05
CH643457A5 (de) 1984-06-15
DE3005029C2 (nl) 1987-02-12
FR2449450B1 (nl) 1983-07-22
IE49073B1 (en) 1985-07-24
BE881763A (fr) 1980-08-18
PH17118A (en) 1984-06-01
GB2044101A (en) 1980-10-15
MY8500619A (en) 1985-12-31
IT8047950A0 (it) 1980-02-20
ATA95580A (de) 1985-03-15
NL8001000A (nl) 1980-08-26
SE8202357L (en) 1982-04-15
IL59432A (en) 1984-08-31
JPS55115823A (en) 1980-09-06
AT378915B (de) 1985-10-25

Similar Documents

Publication Publication Date Title
AU557349B2 (en) Oil treatment composition
AU6146780A (en) Rtv-silicone composition
AU531173B2 (en) Silicone composition
AU532590B2 (en) Silicone composition
AU530726B2 (en) Silicone composition
AU5717980A (en) Photopolymerizable composition
AU524820B2 (en) Corticosteroid compositions
AU6163180A (en) Anti-diarrohoea composition
AU535400B2 (en) Wirebroadcast and viewphone
AU530840B2 (en) Combine
AU535880B2 (en) 5h-furanone-2 and 3h-dihydrofuranone-2 derivatives
AU531541B2 (en) Tickicidal composition
AU532306B2 (en) Tanning processes and compositions
AU535002B2 (en) Phosphine-releasing composition
AU532293B2 (en) Ergol-8-ene and ergolin compounds
AU534751B2 (en) Anti-perspirant compositions
AU538599B2 (en) Compositions and treatment for hypertension
AU525314B2 (en) Peroxydicorbonate composition
AU542556B2 (en) Composition
AU534902B2 (en) Oral composition
AU531211B2 (en) Nalbuphine composition
AU522673B2 (en) Polybutene compositions
AU534419B2 (en) Synergistic tickicidal composition
AU536560B2 (en) Hair treatment composition
AU5628280A (en) 1-epi-fortimicin and derivatives